Do I need to continue taking sparsentan/sparsentan?

Sparsentan/Sparsentan is a key drug in the treatment of primary immunoglobulin A (IgA) nephropathy. Its core function is to reduce the protein content in urine. Although the drug has shown remarkable effects in disease control, many patients have questions about the duration of sparsentan medication, which involves the correct use of the drug, therapeutic effect and safety.

Sparsentan reduces kidney inflammation and damage by inhibiting the activity of endothelin and angiotensinII. This mechanism makes it effective in managing symptoms associated with IgA nephropathy, especially proteinuria. However, we must be clear that sparsentin does not cure the disease; it plays more of a role in disease control. Therefore, it is particularly important to take this drug continuously and stably. Even if the patient feels that his physical condition has improved after receiving treatment, he should not interrupt the medication at will. Because stopping the drug is likely to cause a recurrence or worsening of the condition, especially the level of proteinuria may rise again.

When formulating a treatment plan, doctors will make personalized adjustments based on the patient's specific conditions. This may include using a lower dose of the drug initially, with dose adjustments after 14 days based on patient response. It is crucial to strictly follow your doctor's instructions, as arbitrary changes in drug dosage may have an adverse effect on the effectiveness of the treatment and may even cause unnecessary side effects.

In addition, some side effects may occur during the use of sparsentane, such as hypotension. Maintaining adequate fluid intake while taking this medication can help prevent hypotension. This also reminds us that during the use of drugs, patients need to pay close attention to their physical condition and communicate with their doctors regularly to ensure that they receive appropriate monitoring and professional guidance throughout the entire treatment process.

Reference materials:https://www.ppcswfl.com/health-library/hw-view.php?DOCHWID=a623018